Segment & Geographic Data Quant-Grade Normalized (live API) API & CSV Delivery

Teligent Inc's Business Segments

Teligent Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.

Segment Data As of FY
Reportable Segments
-
Per the company's own filing, this quarter
Largest Segment
-
Total Revenue
$ 10
Consolidated, this quarter
Regions Reported
1
Geographic regions, this quarter
API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/TLGT/segments
https://api.csimarket.com/api/v1/companies/TLGT/geographic
https://api.csimarket.com/api/v1/companies/TLGT/exposure
Programmatic access for models, analytics, and integration workflows.
Dataset & schema
https://api.csimarket.com/api/datasets/business_segments
https://api.csimarket.com/api/schema/business_segments
https://api.csimarket.com/api/meta/business_segments

Teligent Inc does not report a distinct business-segment axis in its filings - its disaggregated revenue is disclosed by product and service category instead. See the Product & Service breakdown below.

Revenue Share by Region - FY

38%largest
  • Geographic Distribution, Foreign38.3%

Revenue by Geographic Region - FY

RegionPeriodRevenue
(Millions)
% of Total
Geographic Distribution, ForeignFY$ 438.3%

Revenue by Product & Service Category - FY

0%largest
  • Company Product0%
  • Topical52.5%
  • Injectables40.7%
  • Contract Manufacturing Sales6.8%
  • Research and Development Services and Other Income0%

Revenue by Product & Service Category - FY

CategoryPeriodRevenue
(Millions)
% of Total
Company ProductFY$ 26-
TopicalFY$ 552.5%
InjectablesFY$ 440.7%

Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.

2 more categories available

Sign in to unlock the full Teligent Inc dataset.

Description of Teligent Inc

Teligent Inc is a global specialty generic pharmaceutical company that develops, manufactures, and markets a wide range of pharmaceutical products. The company is headquartered in Buena, New Jersey.

Teligent focuses on developing and manufacturing affordable, high-quality generic prescription and over-the-counter (OTC) pharmaceutical products. Their product portfolio includes topical creams, ointments, gels, solutions, and suspensions, as well as injectable, sterile, and non-sterile products. They also offer contract manufacturing services for various pharmaceutical companies.

The company is committed to providing cost-effective and accessible medications to healthcare providers and patients. They target niche and under-served markets, aiming to deliver innovative solutions to meet the needs of patients. Teligent efficiently develops pharmaceutical products through in-house research and development, strategic partnerships, and acquisitions.

Teligent's manufacturing facilities are equipped with state-of-the-art technology and comply with strict quality standards. They ensure that their products adhere to the regulatory requirements of the United States Food and Drug Administration (FDA) and other international regulatory bodies. Their facilities have pharmaceutical development labs, a microbiology laboratory, and multiple manufacturing suites for different dosage forms.

The company has a dedicated sales force that promotes their products to healthcare professionals across the United States. They also have a global sales and distribution network to reach international markets. Teligent's products are available in various dosage forms, strengths, and sizes, allowing physicians to prescribe the right medication for their patients.

Teligent's main therapeutic areas include topical dermatology, sterile injectables, and complex specialty products. They continuously expand their product portfolio by developing new drug formulations and seeking licensing or partnership opportunities. They collaborate with research institutions, contract research organizations, and other industry stakeholders to enhance their product pipeline.

Teligent is committed to sustainability and follows environmentally-friendly practices. They strive to reduce their carbon footprint by adopting energy-efficient technologies, optimizing waste management, and minimizing water consumption in their manufacturing processes.

The company's financial performance is driven by their product sales, contract manufacturing revenues, and strategic collaborations. They continue to invest in research and development to maintain their competitive edge in the generic pharmaceutical industry.

In summary, Teligent Inc is a specialty generic pharmaceutical company that develops, manufactures, and markets a diverse range of affordable and high-quality generic prescription and OTC pharmaceutical products. They strive to meet the medical needs of patients, while maintaining strict quality standards and adhering to regulatory requirements. With a focus on innovation, sustainability, and global growth, Teligent is committed to making healthcare more accessible and affordable.
Teligent Inc. is a significant player in the pharmaceutical and healthcare sector, primarily engaged in the development and commercialization of generic and specialty pharmaceuticals. Here, we will provide an extensive overview of the segments, products, and services that Teligent offers.

Segments

Teligent operates primarily in the pharmaceutical industry, focusing on both generic and specialty drug markets. The company is organized into various segments comprising:

1. Generic Pharmaceuticals: This segment includes a wide range of generic medications that Teligent formulates and manufactures. The products in this segment encompass oral solids, injectables, and topical formulations, addressing a comprehensive spectrum of therapeutic areas.

2. Specialty Pharmaceuticals: In this sector, Teligent focuses on more complex products, including niche markets where there is less competition, often represented by unique formulations or specific patient needs. This segment highlights Teligent’s ability to innovate and adapt to specialized healthcare requirements.

3. Contract Manufacturing Services: Teligent offers contract manufacturing services to other pharmaceutical companies, leveraging its facilities and expertise to produce products on behalf of partners. This service combines both the provision of raw materials and the manufacturing process.

4. Regulatory Affairs and Compliance Services: Teligent has a strong focus on ensuring all its products meet regulatory standards for safety and efficacy. This segment includes assistance with the regulatory submission processes and ongoing compliance for both internal and third-party products.

Products

Teligent boasts a diverse portfolio of products, primarily in the following categories:

1. Injectable Products: Teligent specializes in sterile injectables, which require rigorous manufacturing standards and extensive regulatory oversight. These products often address critical care needs and may be directed towards hospitals and healthcare settings.

2. Topical Products: The company offers a range of topical formulations, including creams, gels, ointments, and lotions. This includes products for dermatological conditions, pain relief, and other therapeutic areas where localized treatment is beneficial.

3. Oral Solid Dosage Forms: Teligents oral solid dosage forms, such as tablets and capsules, serve several therapeutic areas and are designed for ease of patient administration. The company emphasizes bioavailability and patient adherence in its formulations.

4. Specialty Products: These are often complex formulations that require specialized manufacturing processes. They may include newer delivery methods or unique formulations for specific patient populations or conditions.

5. Biosimilars and Biologics: Depending on market dynamics, Teligent investigates the development of biosimilars aimed at providing cost-effective alternatives to existing biologic therapies.

Services

Teligent offers a wide array of services beyond its product offerings:

1. Regulatory Services: The company has expertise in managing the regulatory landscape, which includes product approvals and compliance with various national and international guidelines.

2. Research and Development (R&D): Teligent invests in R&D to innovate and improve existing products while developing new therapies. This includes not only formulation development but also providing clinical trial support.

3. Quality Assurance: Teligent emphasizes quality in all its operations, implementing stringent quality control measures to ensure the safety and efficacy of its products.

4. Supply Chain Management: Teligent manages a robust supply chain to ensure timely delivery of its products to market. This includes raw material procurement, inventory management, and distribution logistics.

5. Customer Support and Education: Teligent maintains a commitment to customer service, offering educational resources and support to healthcare professionals and patients alike, ensuring they have the necessary information regarding the safe and effective use of its products.

Conclusion

Teligent Inc. operates at the intersection of innovation and compliance within the pharmaceutical landscape. With a focus on generic and specialty pharmaceuticals, a commitment to quality, and a range of additional services, the company positions itself as a versatile and reliable partner in the healthcare industry. Its diverse portfolio includes a variety of products designed to meet the needs of patients and healthcare providers, supported by robust regulatory and manufacturing capabilities.
,